Occudo Quantitative Strategies’s DexCom DXCM Stock Holding History

Occudo Quantitative Strategies’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-19,906	Closed	-$1.19M	–	817
2026 Q1	$1.19M	Buy	+19,906	New	+$1.39M	0.06%	358
2024 Q4	–	Sell	-5,113	Closed	-$343K	–	742
2024 Q3	$343K	Buy	+5,113	New	+$420K	0.06%	405
2023 Q4	–	Sell	-9,210	Closed	-$859K	–	892
2023 Q3	$859K	Buy	+9,210	New	+$1.04M	0.11%	313
2022 Q1	–	Sell	-9,528	Closed	-$1.28M	–	1170
2021 Q4	$1.28M	Buy	+9,528	New	+$1.37M	0.11%	277
2021 Q2	–	Sell	-2,340	Closed	-$210K	–	919
2021 Q1	$210K	Buy	+2,340	New	+$220K	0.05%	604

Other funds holding DXCM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Occudo Quantitative Strategies's DXCM Position: Q2 2026 in Review

Occudo Quantitative Strategies sold out of DexCom (DXCM) in Q2 2026, closing a stake of 19,906 shares — an estimated $1.19M sold.

Occudo Quantitative Strategies first reported a position in DXCM in Q1 2021 and held it in 5 quarters. The position peaked at $1.28M in Q4 2021. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

Occudo Quantitative Strategies reported no remaining DexCom position as of Q2 2026 after selling out during the quarter.
Occudo Quantitative Strategies sold 19,906 DexCom shares in Q2 2026, an estimated $1.19M.
Occudo Quantitative Strategies first reported a position in DexCom in Q1 2021 and held it in 5 quarters.
Occudo Quantitative Strategies's DexCom position peaked at $1.28M in Q4 2021.
968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Occudo Quantitative Strategies's 13F filing for Q2 2026, filed 13 Aug 2026.